Sanofi (SNY) Free Cash Flow (2009 - 2025)

Sanofi (SNY) has 10 years of Free Cash Flow data on file, last reported at $2.0 billion in Q1 2026.

• Quarterly Free Cash Flow fell 10.5% year-over-year to $2.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.4 billion (up 5.27% YoY) and the FY2025 annual result came in at $8.4 billion, up 33.47% from the prior year.
• Free Cash Flow slipped to $2.0 billion in Q1 2026 per SNY's latest filing, from $11.2 billion in the prior quarter.
• The five-year high for Free Cash Flow was $12.0 billion in Q4 2023, with the low at $95.6 million in Q1 2024.
• Average Free Cash Flow over 5 years is $5.2 billion, with a median of $3.1 billion recorded in 2022.
• Year-over-year, Free Cash Flow plunged 96.76% in 2024 and soared 2202.93% in 2025.
• Sanofi's Free Cash Flow stood at $11.2 billion in 2022, then rose by 6.9% to $12.0 billion in 2023, then retreated by 12.22% to $10.5 billion in 2024, then climbed by 6.97% to $11.2 billion in 2025, then plunged by 82.47% to $2.0 billion in 2026.
• Business Quant data shows SNY's Free Cash Flow at $2.0 billion in Q1 2026, $11.2 billion in Q4 2025, and $8.5 billion in Q3 2025.